<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(11)</volume><submitter>Merino D</submitter><pubmed_abstract>Antipsychotic drugs (APs) aim to treat schizophrenia, bipolar mania, and behavioral symptoms. In child psychiatry, despite limited evidence regarding their efficacy and safety, APs are increasingly subject to off-label use. Studies investigating addictology-related symptoms in young people being scarce, we aimed to characterize the different patterns of AP misuse and withdrawal in children and adolescents relying on the WHO pharmacovigilance database (VigiBase&lt;sup>®&lt;/sup>, Uppsala Monitoring Centre, Sweden). Using the standardized MedDRA Query 'drug abuse, dependence and withdrawal', disproportionality for each AP was assessed with the reporting odds ratio and the information component. A signal was detected when the lower end of the 95% confidence interval of the information component was</pubmed_abstract><journal>Biomedicines</journal><pagination>2972</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9687123</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis.</pubmed_title><pmcid>PMC9687123</pmcid><pubmed_authors>Destere A</pubmed_authors><pubmed_authors>Drici MD</pubmed_authors><pubmed_authors>Thummler S</pubmed_authors><pubmed_authors>Merino D</pubmed_authors><pubmed_authors>Gerard AO</pubmed_authors><pubmed_authors>Askenazy F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis.</name><description>Antipsychotic drugs (APs) aim to treat schizophrenia, bipolar mania, and behavioral symptoms. In child psychiatry, despite limited evidence regarding their efficacy and safety, APs are increasingly subject to off-label use. Studies investigating addictology-related symptoms in young people being scarce, we aimed to characterize the different patterns of AP misuse and withdrawal in children and adolescents relying on the WHO pharmacovigilance database (VigiBase&lt;sup>®&lt;/sup>, Uppsala Monitoring Centre, Sweden). Using the standardized MedDRA Query 'drug abuse, dependence and withdrawal', disproportionality for each AP was assessed with the reporting odds ratio and the information component. A signal was detected when the lower end of the 95% confidence interval of the information component was</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-05-18T12:01:46.021Z</modification><creation>2025-05-18T12:01:46.021Z</creation></dates><accession>S-EPMC9687123</accession><cross_references><pubmed>36428541</pubmed><doi>10.3390/biomedicines10112972</doi></cross_references></HashMap>